Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

11/09/2026

Aggiornamento "Diario di bordo sulla Trasparenza"

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

10/09/2026

Ambiente Informa n.669 del 10 settembre 2026

Agendas and minutes

09/09/2026

Agenda of the PRAC meeting 31 August - 3 September 2026

Consumer Updates RSS Feed

10/09/2026

Tips to Stay Safe in the Sun: From Sunscreen to Sunglasses

Regulatory and procedural guidelines (human and veterinary)

08/09/2026

Member states contact points for translations review

Scientific guidelines (human and veterinary)

11/09/2026

Draft guideline on the investigation of interactions in the gastrointestinal tract

Paediatric investigation plans

04/09/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyclarys, omaveloxolone, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000338563

Orphan designations

26/08/2026

Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn

New medicines and opinions: human

09/09/2026

Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion

MedWatch Safety Alerts RSS Feed

10/09/2026

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

What's New: Drugs RSS Feed

10/09/2026

Rare Diseases at FDA

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis